The domestic cat as a natural animal model of Alzheimer’s disease

[1]  C. Vite,et al.  Aging in the canine and feline brain. , 2014, The Veterinary clinics of North America. Small animal practice.

[2]  S. Itohara,et al.  Single App knock-in mouse models of Alzheimer's disease , 2014, Nature Neuroscience.

[3]  A. Takashima,et al.  Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice , 2014, Acta Neuropathologica.

[4]  Naruhiko Sahara,et al.  “Tau Oligomers,” What We Know and What We Don’t Know , 2014, Front. Neurol..

[5]  E. Head.  A canine model of human aging and Alzheimer's disease. , 2013, Biochimica et biophysica acta.

[6]  C. Cotman,et al.  Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models. , 2013, The American journal of pathology.

[7]  David A Bennett,et al.  Brain amyloid-β oligomers in ageing and Alzheimer's disease. , 2013, Brain : a journal of neurology.

[8]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[9]  H. Nakayama,et al.  Neurofibrillary Tangles and the Deposition of a Beta Amyloid Peptide with a Novel N-Terminal Epitope in the Brains of Wild Tsushima Leopard Cats , 2012, PloS one.

[10]  K. Blennow,et al.  Amyloid-β metabolism in Niemann-Pick C disease models and patients , 2012, Metabolic Brain Disease.

[11]  M. Nishizawa,et al.  Hyperphosphorylation of Tau Induced by Naturally Secreted Amyloid-β at Nanomolar Concentrations Is Modulated by Insulin-dependent Akt-GSK3β Signaling Pathway* , 2012, The Journal of Biological Chemistry.

[12]  T. Tokuda,et al.  Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for Aβ oligomers. , 2012, Biochemical and biophysical research communications.

[13]  K. Blennow,et al.  An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid. , 2012, Journal of mass spectrometry : JMS.

[14]  Yun-Ru Chen,et al.  Amyloid-Beta (Aβ) D7H Mutation Increases Oligomeric Aβ42 and Alters Properties of Aβ-Zinc/Copper Assemblies , 2012, PloS one.

[15]  Y. Une,et al.  Beta Amyloid Deposition and Neurofibrillary Tangles Spontaneously Occur in the Brains of Captive Cheetahs (Acinonyx jubatus) , 2012, Veterinary pathology.

[16]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[17]  D. Selkoe,et al.  Resolving controversies on the path to Alzheimer's therapeutics , 2011, Nature Medicine.

[18]  H. Nakayama,et al.  Characterization of AβpN3 deposition in the brains of dogs of various ages and other animal species , 2011, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[19]  Jürgen Götz,et al.  Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease , 2011, Nature Reviews Neuroscience.

[20]  Ezzie Hutchinson,et al.  Systems neuroscience: The stress of dieting , 2011, Nature Reviews Neuroscience.

[21]  J. Marsh,et al.  Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers , 2010, Molecular Neurodegeneration.

[22]  T. Tokuda,et al.  High-molecular weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients , 2010, Alzheimer's & Dementia.

[23]  T. Tokuda,et al.  High-molecular weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients , 2010, Alzheimer's & Dementia.

[24]  Ville Leinonen,et al.  Immunohistochemical visualization of amyloid-beta protein precursor and amyloid-beta in extra- and intracellular compartments in the human brain. , 2010, Journal of Alzheimer's disease : JAD.

[25]  D. Teplow,et al.  Effects of the English (H6R) and Tottori (D7N) Familial Alzheimer Disease Mutations on Amyloid β-Protein Assembly and Toxicity* , 2010, The Journal of Biological Chemistry.

[26]  Rie Teraoka,et al.  A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.

[27]  E. Capetillo-Zarate,et al.  Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease , 2010, Acta Neuropathologica.

[28]  M. Capucchio,et al.  Parenchymal and vascular lesions in ageing equine brains: histological and immunohistochemical studies. , 2010, Journal of comparative pathology.

[29]  H. Vinters,et al.  β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin , 2009, The Journal of Neuroscience.

[30]  C. Robinson,et al.  Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. , 2009, Nature chemistry.

[31]  E. Bigio,et al.  Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers , 2008, Neurobiology of Aging.

[32]  Giovanni Coppola,et al.  Tauopathy with paired helical filaments in an aged chimpanzee , 2008, The Journal of comparative neurology.

[33]  J. Götz,et al.  Animal models of Alzheimer's disease and frontotemporal dementia , 2008, Nature Reviews Neuroscience.

[34]  Yasuyoshi Watanabe,et al.  A new amyloid β variant favoring oligomerization in Alzheimer's‐type dementia , 2008, Annals of neurology.

[35]  C. Cotman,et al.  Region specific neuron loss in the aged canine hippocampus is reduced by enrichment , 2008, Neurobiology of Aging.

[36]  E. Bigio,et al.  Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers. , 2008, Neurobiology of aging.

[37]  C. Duyckaerts,et al.  Alzheimer disease models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.

[38]  S. Frank,et al.  Tauopathy models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.

[39]  K. Arima.  Ultrastructural characteristics of tau filaments in tauopathies: Immuno‐electron microscopic demonstration of tau filaments in tauopathies , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[40]  E. Head,et al.  Ageing changes in cat brains demonstrated by β-amyloid and AT8-immunoreactive phosphorylated tau deposits , 2006, Journal of feline medicine and surgery.

[41]  Agostinho Antunes,et al.  The Late Miocene Radiation of Modern Felidae: A Genetic Assessment , 2006, Science.

[42]  F. LaFerla,et al.  A dynamic relationship between intracellular and extracellular pools of Abeta. , 2006, The American journal of pathology.

[43]  F. LaFerla,et al.  Copyright © American Society for Investigative Pathology DOI: 10.2353/ajpath.2006.050593 Molecular Pathogenesis of Genetic and Inherited Diseases A Dynamic Relationship between Intracellular and Extracellular Pools of A� , 2022 .

[44]  H. Braak,et al.  Apolipoprotein E co-localizes with newly formed amyloid β-protein (Aβ) deposits lacking immunoreactivity against N-terminal epitopes of Aβ in a genotype-dependent manner , 2005, Acta Neuropathologica.

[45]  C. Cotman,et al.  β-Amyloid deposition and tau phosphorylation in clinically characterized aged cats , 2005, Neurobiology of Aging.

[46]  Gudrun Wacker.  Similarities and Differences , 2005 .

[47]  H. Braak,et al.  Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. , 2005, Acta neuropathologica.

[48]  C. Duyckaerts,et al.  Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. , 2004, The American journal of pathology.

[49]  Thomas Arendt,et al.  Tau gene (MAPT) sequence variation among primates. , 2004, Gene.

[50]  Mark J West,et al.  Hippocampal neurons in pre-clinical Alzheimer’s disease , 2004, Neurobiology of Aging.

[51]  K. Uetsuka,et al.  Senile plaques in an aged two-humped (Bactrian) camel (Camelus bactrianus) , 2004, Acta Neuropathologica.

[52]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[53]  Manjit,et al.  Neurology , 1912, NeuroImage.

[54]  T. Arendt,et al.  Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders. , 1999, Brain research. Molecular brain research.

[55]  H. Akiyama,et al.  Glial Tau Pathology in Neurodegenerative Diseases: Their Nature and Comparison with Neuronal Tangles , 1998, Neurobiology of Aging.

[56]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[57]  Brian J Cummings,et al.  Diffuse plaques contain C-terminal Aβ 42 and not Aβ 40: Evidence from cats and dogs , 1996, Neurobiology of Aging.

[58]  Brian J Cummings,et al.  Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs. , 1996, Neurobiology of aging.

[59]  H. Nakayama,et al.  Senile Plaques and Other Senile Changes in the Brain of an Aged American Black Bear , 1995, Veterinary pathology.

[60]  B T Hyman,et al.  Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[61]  T. Shirasawa,et al.  Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues. , 1994, The Journal of biological chemistry.

[62]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[63]  N. Cairns,et al.  Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms , 1992, Neuron.

[64]  S. Little,et al.  Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. , 1991, Brain research. Molecular brain research.

[65]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[66]  D. Price,et al.  Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. , 1987, Science.

[67]  J. Nunez,et al.  Immunological characterization of microtubule‐associated proteins specific for the immature brain , 1985, FEBS letters.

[68]  S. L. Bonting,et al.  Life Sciences , 1984, Science.

[69]  K. Abromeit.  Music Received , 2023, Notes.